Trexquant Investment’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-272,774
| Closed | -$13.3M | – | 1842 |
|
|
2025
Q2 | $13.3M | Buy |
272,774
+78,975
| +41% | +$3.75M | 0.15% | 173 |
|
|
2025
Q1 | $9.88M | Sell |
193,799
-119,618
| -38% | -$5.97M | 0.11% | 255 |
|
|
2024
Q4 | $14.1M | Buy |
313,417
+95,418
| +44% | +$4.08M | 0.16% | 174 |
|
|
2024
Q3 | $8.09M | Sell |
217,999
-80,423
| -27% | -$2.69M | 0.1% | 299 |
|
|
2024
Q2 | $9.13M | Buy |
298,422
+28,008
| +10% | +$907K | 0.14% | 214 |
|
|
2024
Q1 | $7.87M | Buy |
270,414
+37,751
| +16% | +$1.06M | 0.16% | 177 |
|
|
2023
Q4 | $6.41M | Buy |
+232,663
| New | +$5.32M | 0.14% | 181 |
|
|
2023
Q1 | – | Sell |
-30,933
| Closed | -$1.18M | – | 1708 |
|
|
2022
Q4 | $1.18M | Sell |
30,933
-11,705
| -27% | -$487K | 0.03% | 594 |
|
|
2022
Q3 | $2.14M | Buy |
42,638
+4,005
| +10% | +$196K | 0.08% | 339 |
|
|
2022
Q2 | $1.55M | Buy |
38,633
+12,573
| +48% | +$441K | 0.07% | 341 |
|
|
2022
Q1 | $972K | Buy |
26,060
+20,373
| +358% | +$785K | 0.05% | 485 |
|
|
2021
Q4 | $227K | Sell |
5,687
-1,461
| -20% | -$55.9K | 0.01% | 1078 |
|
|
2021
Q3 | $266K | Sell |
7,148
-104
| -1% | -$4.27K | 0.02% | 802 |
|
|
2021
Q2 | $307K | Buy |
+7,252
| New | +$311K | 0.03% | 695 |
|
|
2020
Q4 | – | Sell |
-13,506
| Closed | -$631K | – | 1399 |
|
|
2020
Q3 | $631K | Buy |
+13,506
| New | +$665K | 0.04% | 578 |
|
|
2020
Q2 | – | Sell |
-6,076
| Closed | -$271K | – | 1405 |
|
|
2020
Q1 | $271K | Sell |
6,076
-8,761
| -59% | -$441K | 0.02% | 888 |
|
|
2019
Q4 | $713K | Buy |
+14,837
| New | +$630K | 0.04% | 457 |
|
|
2019
Q3 | – | Sell |
-13,075
| Closed | -$588K | – | 1069 |
|
|
2019
Q2 | $588K | Buy |
13,075
+5,166
| +65% | +$204K | 0.05% | 435 |
|
|
2019
Q1 | $298K | Buy |
+7,909
| New | +$266K | 0.02% | 751 |
|
|
2018
Q4 | – | Sell |
-24,409
| Closed | -$1.15M | – | 1259 |
|
|
2018
Q3 | $1.15M | Sell |
24,409
-42,817
| -64% | -$1.77M | 0.09% | 325 |
|
|
2018
Q2 | $2.27M | Buy |
+67,226
| New | +$2.1M | 0.16% | 208 |
|
|
2017
Q1 | – | Sell |
-39,181
| Closed | -$427K | – | 1277 |
|
|
2016
Q4 | $427K | Buy |
+39,181
| New | +$411K | 0.07% | 511 |
|
|
2016
Q2 | – | Sell |
-36,096
| Closed | -$232K | – | 1053 |
|
|
2016
Q1 | $232K | Buy |
+36,096
| New | +$626K | 0.03% | 811 |
|
|
2015
Q4 | – | Sell |
-110,461
| Closed | -$2.95M | – | 1222 |
|
|
2015
Q3 | $2.95M | Buy |
+110,461
| New | +$4.72M | 0.25% | 67 |
|
|
2015
Q2 | – | Sell |
-25,100
| Closed | -$1.53M | – | 1190 |
|
|
2015
Q1 | $1.53M | Buy |
25,100
+18,000
| +254% | +$1.1M | 0.16% | 205 |
|
|
2014
Q4 | $367K | Buy |
+7,100
| New | +$313K | 0.06% | 598 |
|
Other funds holding PTCT
RI
AC
Trexquant Investment's PTCT Position: Q3 2025 in Review
Trexquant Investment sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 272,774 shares — an estimated $13.3M sold.
Trexquant Investment first reported a position in PTCT in Q4 2014 and held it in 26 quarters. The position peaked at $14.1M in Q4 2024. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.
- Trexquant Investment reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
- Trexquant Investment sold 272,774 PTC Therapeutics shares in Q3 2025, an estimated $13.3M.
- Trexquant Investment first reported a position in PTC Therapeutics in Q4 2014 and held it in 26 quarters.
- Trexquant Investment's PTC Therapeutics position peaked at $14.1M in Q4 2024.
- 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.
Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.